Life Health Tech Firm Adapts for Medicare's Chronic Care Initiative A remote patient monitoring company is adapting its technology to participate in Medicare's ACCESS experiment, which aims to improve health care outcomes through aligned payments. editorial-staff Apr 13
Life Trump's Approach to Health Insurance Raises Questions Despite President Trump's promises to challenge health insurers, his policies appear to contradict those commitments, suggesting a softer stance. editorial-staff Apr 13
Life Revolution Medicines Reports Promising Data for Pancreatic Cancer Treatment In a recent trial, patients with metastatic pancreatic cancer who received a new medication from Revolution Medicines reportedly lived twice as long as those treated with chemotherapy. editorial-staff Apr 13
Life Navigating the Challenges of Elevating Nurses to Health Expert Roles As the healthcare landscape evolves, the transition of nurses into expert roles presents both opportunities and challenges, with implications for future healthcare delivery. editorial-staff Apr 13
Life Promising Advances in Allogene Therapeutics’ CAR-T Treatment for B-cell Lymphoma Recent findings indicate that Allogene Therapeutics’ CAR-T therapy effectively targets residual cancer cells in B-cell lymphoma patients, potentially delaying recurrence. editorial-staff Apr 13
Life Spyre Therapeutics' IBD Drug Demonstrates Potential in Initial Trials Spyre Therapeutics has reported positive results from its first major trial of a drug aimed at treating inflammatory bowel disease, positioning itself against larger pharmaceutical companies. editorial-staff Apr 13
Life Hospitals Introduce Chatbots to Improve Patient Interaction Several hospitals are beginning to implement chatbots, a bold move intended to enhance communication with existing patients while attracting new ones. editorial-staff Apr 13
Life Understanding Erectile Dysfunction: A Broader Perspective Erectile dysfunction extends beyond mere sexual concerns, impacting various aspects of life and well-being. editorial-staff Apr 13
Life Challenges Ahead for Vinay Prasad’s Successor at the FDA The position of head of the FDA's Center for Biologics Evaluation and Research presents significant challenges for any successor. editorial-staff Apr 13